Staxyn - 0173-0822-61 - (vardenafil hydrochloride)

Alphabetical Index


Drug Information of Staxyn

Product NDC: 0173-0822
Proprietary Name: Staxyn
Non Proprietary Name: vardenafil hydrochloride
Active Ingredient(s): 11.85    mg/1 & nbsp;   vardenafil hydrochloride
Administration Route(s): ORAL
Dosage Form(s): TABLET, ORALLY DISINTEGRATING
Coding System: National Drug Codes(NDC)

Labeler Information of Staxyn

Product NDC: 0173-0822
Labeler Name: GlaxoSmithKline LLC
Product Type: HUMAN PRESCRIPTION DRUG
FDA Application Number: NDA200179
Marketing Category: NDA
Start Marketing Date: 20110421

Package Information of Staxyn

Package NDC: 0173-0822-61
Package Description: 1 BLISTER PACK in 1 BOX (0173-0822-61) > 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK

NDC Information of Staxyn

NDC Code 0173-0822-61
Proprietary Name Staxyn
Package Description 1 BLISTER PACK in 1 BOX (0173-0822-61) > 2 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK
Product NDC 0173-0822
Product Type Name HUMAN PRESCRIPTION DRUG
Non Proprietary Name vardenafil hydrochloride
Dosage Form Name TABLET, ORALLY DISINTEGRATING
Route Name ORAL
Start Marketing Date 20110421
Marketing Category Name NDA
Labeler Name GlaxoSmithKline LLC
Substance Name VARDENAFIL HYDROCHLORIDE TRIHYDRATE
Strength Number 11.85
Strength Unit mg/1
Pharmaceutical Classes Phosphodiesterase 5 Inhibitor [EPC],Phosphodiesterase 5 Inhibitors [MoA]

Complete Information of Staxyn


General Information